Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis

Minopoulou I, Wilhelm A, Albach F, Kleyer A, Wiebe E, Schallenberg S, Fleischmann A, Frick M, Damm F, Gogolok J, Serve S, Locher BN, Borie D, Casteleyn V, Biesen R, Dörner T, Alexander T, Zernicke J, Movassaghi K, Hütter-Krönke ML, Schrezenmeier E, Schreiber A, Schneider U, Bullinger L, Krönke G, Penack O, Simon D (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

DOI: 10.1016/j.ard.2025.01.008

Involved external institutions

Charité - Universitätsmedizin Berlin DE Germany (DE) Deutsches Rheuma-Forschungszentrum (DRFZ) DE Germany (DE) Kyverna Therapeutics, Inc. US United States (USA) (US)

How to cite

APA:

Minopoulou, I., Wilhelm, A., Albach, F., Kleyer, A., Wiebe, E., Schallenberg, S.,... Simon, D. (2025). Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.01.008

MLA:

Minopoulou, Ioanna, et al. "Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis." Annals of the Rheumatic Diseases (2025).

BibTeX: Download